Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Brain. 2019 Aug 1;142(8):2380-2401. doi: 10.1093/brain/awz172.
α-Synuclein misfolding and aggregation plays a major role in the pathogenesis of Parkinson's disease. Although loss of function mutations in the ubiquitin ligase, parkin, cause autosomal recessive Parkinson's disease, there is evidence that parkin is inactivated in sporadic Parkinson's disease. Whether parkin inactivation is a driver of neurodegeneration in sporadic Parkinson's disease or a mere spectator is unknown. Here we show that parkin in inactivated through c-Abelson kinase phosphorylation of parkin in three α-synuclein-induced models of neurodegeneration. This results in the accumulation of parkin interacting substrate protein (zinc finger protein 746) and aminoacyl tRNA synthetase complex interacting multifunctional protein 2 with increased parkin interacting substrate protein levels playing a critical role in α-synuclein-induced neurodegeneration, since knockout of parkin interacting substrate protein attenuates the degenerative process. Thus, accumulation of parkin interacting substrate protein links parkin inactivation and α-synuclein in a common pathogenic neurodegenerative pathway relevant to both sporadic and familial forms Parkinson's disease. Thus, suppression of parkin interacting substrate protein could be a potential therapeutic strategy to halt the progression of Parkinson's disease and related α-synucleinopathies.
α-突触核蛋白错误折叠和聚集在帕金森病的发病机制中起主要作用。虽然泛素连接酶 parkin 的功能丧失突变导致常染色体隐性帕金森病,但有证据表明 parkin 在散发性帕金森病中失活。parkin 失活是散发性帕金森病神经退行性变的驱动因素还是旁观者尚不清楚。在这里,我们表明 parkin 通过 c-Abelson 激酶在三种α-突触核蛋白诱导的神经退行性变模型中对 parkin 的磷酸化而失活。这导致 parkin 相互作用底物蛋白(锌指蛋白 746)和氨酰 tRNA 合成酶复合物相互作用多功能蛋白 2 的积累,增加的 parkin 相互作用底物蛋白水平在α-突触核蛋白诱导的神经退行性变中起着关键作用,因为 parkin 相互作用底物蛋白的敲除可减轻退行性过程。因此,parkin 相互作用底物蛋白的积累将 parkin 失活与α-突触核蛋白联系在与散发性和家族性帕金森病相关的共同致病神经退行性途径中。因此,抑制 parkin 相互作用底物蛋白可能是阻止帕金森病和相关α-突触核蛋白病进展的潜在治疗策略。